Digital Healthcare Company Truepill and medtech prescription specialist ScriptDrop have partnered to integrate ScriptDrop’s same-day prescription delivery service with Truepill’s pharmacy platform, allowing patients to choose their own pharmacy for medication delivery through ScriptDrop’s two-hour service.
The partnership allows patients to visit their local pharmacies and gives pharmacists an outlet to interact directly with patients.
The partnership with ScriptDrop expands Truepill’s fulfillment options by enabling same-day delivery nationwide, in addition to retail pick-up and mail order fulfillment through Truepill pharmacies.
“By integrating ScriptDrop’s efficient same-day delivery service into our comprehensive digital pharmacy platform, we are giving patients more choice to meet their individual needs and treatment requirements, ensuring a seamless, reliable experience from prescription to doorstep,” TruePill CEO Paul Greenall said in a statement.
“This collaboration with ScriptDrop marks a major milestone in our mission to deliver patient-centric care and is a testament to why Truepill remains the first choice for life sciences leaders who want to provide patients with frictionless access to medications combined with the highest quality multi-modal pharmacy support.”
Larger trends
In 2022, The Drug Enforcement Administration (DEA) issued a show cause order to True Pill for illegally dispensing thousands of prescription stimulants used to treat ADHD, including Adderall.
The DEA alleges that the company filled more than 72,000 prescriptions for controlled substances between September 2020 and September 2022, 60% of which were stimulants, including generic versions of Adderall.
According to the department, True Pill dispensed controlled substances for prescriptions that were not issued for legitimate medical purposes, illegally exceeded 90-day supply limits, and filled prescriptions written by prescribing physicians who did not have the appropriate state licenses.
That same year, Trupil partnered with COVID-19 testing company Curative to provide patients with access to Trupil’s COVID-19 virtual care platform, Sid Viswanathan was appointed CEO.
In 2021, Truepill The company raised $142 million in Series D funding, bringing its total funding to $256 million and its valuation to $1.6 billion. The company secured $75 million in Series C funding a year ago, two months after raising $25 million in a Series B funding round.
vinegarCryptDrop raised $15 million in a growth round in 2020, bringing its total funding to $27 million in 2022. Oio Innovation Fund, M25 and Rev1 Ventures participated in the investment.
last year, Uber Health partnered with ScriptDrop to manage prescription delivery from pharmacies in its service area and allow users to track when their prescriptions will arrive.
The HIMSS AI in Healthcare Forum is scheduled to take place in Boston from September 5 to 6. More information and registration.
